Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids

Video

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Related Videos
Rupa Wong, MD | Image Credit: Rupa Wong, MD
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
John Bradley, MD
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Pfizer's infant RSV vaccine receives FDA Advisory Committee's support | Image Credit: Dr_Microbe - Image Credit: Dr_Microbe
Tina Tan, MD
Related Content
Contemporary Pediatrics week in review: FDA approved sickle cell treatments, pediatric pneumonia, and more

Contemporary Pediatrics week in review: FDA approved sickle cell treatments, pediatric pneumonia, and more

December 9th 2023
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

FDA approves pair of gene therapies to treat patients with sickle cell disease

FDA approves pair of gene therapies to treat patients with sickle cell disease

December 8th 2023
Article

Sickle cell disease (SCD) patients aged 12 years and up can now be treated with exa-cel and lovo-cel, following simultaneous approval from the FDA on December 8, 2023.

World’s first chikungunya vaccine FDA approved for individuals 18 years and up | Image Credit: © syahrir - © syahrir - stock.adobe.com.

World’s first chikungunya vaccine FDA approved for individuals 18 years and up

November 10th 2023
Article

The US approval makes VLA1553 (Ixchiq; Valneva) the world’s first licensed chikungunya vaccine.

FDA grants De Novo clearance to Owlet’s Dream Sock: © Andrey - stock.adobe.com

FDA grants De Novo clearance to Owlet’s Dream Sock

November 9th 2023
Article

This decision makes Owlet’s Dream Sock the first and only over-the-counter medical-grade pulse oximeter that is cleared for use in infants, according to the company.

Ustekinumab biosimilar approved for children 6 years and up with plaque psoriasis, psoriatic arthritis | Image Credit: © Calin- © Calin - stock.adobe.com.

Ustekinumab biosimilar approved for children 6 years and up with plaque psoriasis, psoriatic arthritis

November 7th 2023
Article

Ustekinumab-auub is approved to treat indications that are currently approved for ustekinumab, including moderate to severe plaque psoriasis (candidates for phototherapy or systemic therapy) and for those with active psoriatic arthritis, aged 6 years and older.

Contemporary Pediatrics week in review: Infant mortality rates, FDA approvals, and more | Image Credit: © Artur - © Artur - stock.adobe.com.

Contemporary Pediatrics week in review: Infant mortality rates, FDA approvals, and more

November 3rd 2023
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

© 2023 MJH Life Sciences

All rights reserved.